in2cure raises SEK 10 million

in2cure has raised SEK 10 million in venture capital from private investors. The company, a member of SmiLe Incubator in Lund, is developing a gel to promote wound healing based on research at Lund University. in2cure is now accelerating development and plans to initiate clinical studies at the end of 2019. Helene Hartman, previously a member of the board of directors, is taking over as the new CEO.

Curida attracts new investors

The Norwegian pharmaceutical manufacturer Curida has attracted yet another strong private investor. Stokke Industri AS joins the Curida team along with Canica, Klaveness Marine and Investinor. Curida has now raised more than 100 million NOK from external investors.

In need of start-up money?

Are you and your cluster company in need of early stage funding? Apply forInnovasjonsrammen by the 10th of September and compete for important start-up money.

Novo Nordisk's operating profit decreased by 8% in Danish kroner and increased by 4% in local currencies in the first six months of 2018

Sales decreased by 5% in Danish kroner and increased by 4% in local currencies to USD 8.8 billion.

AbbVie Commences Self-Tender Offer for Up to $7.5 Billion of its Common Stock

AbbVie Reports First-Quarter 2018 Financial Results